Back
Century Aluminum 10K Form
Buy
72
CENX
Century Aluminum
Last Price:
$19.95
Seasonality Move:
11.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | CENX/Century Aluminum Quarterly |
2024-03-15 | 10K | CENX/Century Aluminum Annual |
2023-11-08 | 10Q | CENX/Century Aluminum Quarterly |
2023-08-09 | 10Q | CENX/Century Aluminum Quarterly |
2023-05-09 | 10Q | CENX/Century Aluminum Quarterly |
2023-02-27 | 10K | CENX/Century Aluminum Annual |
Receive CENX News And Ratings
See the #1 stock for the next 7 days that we like better than CENX
CENX Financial Statistics
Sales & Book Value
Annual Sales: | $2.2B |
---|---|
Cash Flow: | $-54.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.44 |
Price / Book: | 2.65 |
Profitability
EPS (TTM): | 3.13000 |
---|---|
Net Income (TTM): | $336.8M |
Gross Margin: | $185M |
Return on Equity: | 60.03% |
Return on Assets: | 18.03% |
Century Aluminum Earnings Forecast
Key Century Aluminum Financial Ratios
-
The Gross Profit Margin over the past 29 years for CENX is 8.33%.
-
The Selling, General & Administrative Expenses for CENX have been equal to 2.56% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 12.80% of Operating Income.
-
The Net Earning history of CENX is 15.17% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 11 years.
Century Aluminum Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | CENX |
CUSIP: | 156431 |
Website: | centuryaluminum.com |
Debt
Debt-to-Equity Ratio: | 0.76 |
---|---|
Current Ratio: | 1.73 |
Quick Ratio: | 0.49 |
Price-to-Earnings
Trailing P/E Ratio: | 6.1 |
---|---|
Forward P/E Ratio: | 10.9 |
CENX Technical Analysis vs Fundamental Analysis
Buy
72
Century Aluminum (CENX)
is a Buy
Is Century Aluminum a Buy or a Sell?
-
Century Aluminum stock is rated a BuyThe current Century Aluminum [CENX] share price is $19.95. The Score for CENX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.